These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29062982)

  • 1. Clinical significance of intratumor heterogeneity for gynecological carcinoma.
    Yang YC; Li XP
    Chronic Dis Transl Med; 2015 Mar; 1(1):14-17. PubMed ID: 29062982
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathological Bases and Clinical Impact of Intratumor Heterogeneity in Clear Cell Renal Cell Carcinoma.
    López JI; Angulo JC
    Curr Urol Rep; 2018 Jan; 19(1):3. PubMed ID: 29374850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are we getting closer to understanding intratumor heterogeneity in hepatocellular carcinoma?
    Hammoud GM; Ibdah JA
    Hepatobiliary Surg Nutr; 2016 Apr; 5(2):188-90. PubMed ID: 27115014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumor Heterogeneity in Breast Cancer.
    Beca F; Polyak K
    Adv Exp Med Biol; 2016; 882():169-89. PubMed ID: 26987535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer.
    Lindström LS; Yau C; Czene K; Thompson CK; Hoadley KA; Van't Veer LJ; Balassanian R; Bishop JW; Carpenter PM; Chen YY; Datnow B; Hasteh F; Krings G; Lin F; Zhang Y; Nordenskjöld B; Stål O; Benz CC; Fornander T; Borowsky AD; Esserman LJ;
    J Natl Cancer Inst; 2018 Jul; 110(7):726-733. PubMed ID: 29361175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumor heterogeneity in clear cell renal cell carcinoma: a review for the practicing pathologist.
    López JI
    APMIS; 2016 Mar; 124(3):153-9. PubMed ID: 26865355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling in cervical cancer: an exploration of intratumor heterogeneity.
    Bachtiary B; Boutros PC; Pintilie M; Shi W; Bastianutto C; Li JH; Schwock J; Zhang W; Penn LZ; Jurisica I; Fyles A; Liu FF
    Clin Cancer Res; 2006 Oct; 12(19):5632-40. PubMed ID: 17020965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Heterogeneity in Breast Cancer.
    Turashvili G; Brogi E
    Front Med (Lausanne); 2017; 4():227. PubMed ID: 29276709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumor heterogeneity in hepatocellular carcinoma.
    Friemel J; Rechsteiner M; Frick L; Böhm F; Struckmann K; Egger M; Moch H; Heikenwalder M; Weber A
    Clin Cancer Res; 2015 Apr; 21(8):1951-61. PubMed ID: 25248380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of intratumor heterogeneity of EGFR mutations in mixed type lung adenocarcinoma.
    Tomonaga N; Nakamura Y; Yamaguchi H; Ikeda T; Mizoguchi K; Motoshima K; Doi S; Nakatomi K; Iida T; Hayashi T; Nagayasu T; Tsukamoto K; Kohno S
    Clin Lung Cancer; 2013 Sep; 14(5):521-6. PubMed ID: 23786997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of intertumor and intratumor heterogeneity in liver cancer.
    Liu J; Dang H; Wang XW
    Exp Mol Med; 2018 Jan; 50(1):e416. PubMed ID: 29303512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass Spectrometry Imaging for the Investigation of Intratumor Heterogeneity.
    Balluff B; Hanselmann M; Heeren RM
    Adv Cancer Res; 2017; 134():201-230. PubMed ID: 28110651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma.
    Zito Marino F; Liguori G; Aquino G; La Mantia E; Bosari S; Ferrero S; Rosso L; Gaudioso G; De Rosa N; Scrima M; Martucci N; La Rocca A; Normanno N; Morabito A; Rocco G; Botti G; Franco R
    PLoS One; 2015; 10(9):e0139264. PubMed ID: 26422230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulation framework for generating intratumor heterogeneity patterns in a cancer cell population.
    Iwasaki WM; Innan H
    PLoS One; 2017; 12(9):e0184229. PubMed ID: 28877206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumor heterogeneity: nature and biological significance.
    Gerashchenko TS; Denisov EV; Litviakov NV; Zavyalova MV; Vtorushin SV; Tsyganov MM; Perelmuter VM; Cherdyntseva NV
    Biochemistry (Mosc); 2013 Nov; 78(11):1201-15. PubMed ID: 24460935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
    Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J
    Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma.
    Guarch R; Lawrie CH; Larrinaga G; Angulo JC; Pulido R; López JI
    Ann Diagn Pathol; 2018 Jun; 34():27-30. PubMed ID: 29661723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights from the widening homogeneity perspective to target intratumor heterogeneity.
    Tong M; Deng Z; Zhang X; He B; Yang M; Cheng W; Liu Q
    Cancer Commun (Lond); 2018 May; 38(1):17. PubMed ID: 29764517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovering intratumor heterogeneity: the next frontier for pathologists.
    López JI; De Petris G
    Pathologica; 2017 Jun; 109(2):110-113. PubMed ID: 28748969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular heterogeneity and molecular evolution in cancer.
    Almendro V; Marusyk A; Polyak K
    Annu Rev Pathol; 2013 Jan; 8():277-302. PubMed ID: 23092187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.